SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,450.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 180.00 (4.091%)
Market Cap: £296.40m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Acquisition

22 Feb 2006 07:01

Judges Capital PLC22 February 2006 FURTHER EXPANSION OF JUDGES CAPITAL VIA ACQUISITION OF UHV DESIGN 22 FEBRUARY 2006 Judges Capital plc ("Judges"), a holding group for companies that specialise inthe design and manufacture of scientific instruments, announces that it hastoday completed the acquisition of 100% of the shares in UHV Design Limited ("UHV"). UHV, based in Laughton, East Sussex, designs and manufactures instruments usedto manipulate objects in Ultra High Vacuum chambers (where the pressure isseveral trillion times less than the atmosphere). The business of UHV wasfounded in 1993 by Paul and Lynne Stonestreet, each of whom owned 50% of theequity. UHV's unaudited accounts for the year ended 31 March 2005 show sales of£954,000, pre-tax profits of £296,000 and net tangible assets of £120,000. The initial consideration paid for UHV by Judges, which also owns Fire TestingTechnology and a controlling shareholding in PE fiberoptics, was £650,000 incash plus 98,522 ordinary shares in Judges. An additional payment will be madeto reflect the working capital available at completion in excess of thetwelve-month average. A maximum earn-out of £86,000 will be payable to thevendors based on UHV achieving certain EBIT targets for the years ending 31March 2006 and 31 March 2007. The initial cash consideration was financed by anextension of Judges' senior loan from Bank of Scotland. Paul Stonestreet will remain Managing Director of UHV for up to one year andwill subsequently become Chief Technology Officer for up to two years fromcompletion. Alex Hambro, Chairman of Judges, commented: "I am delighted that we havecompleted our third acquisition in the scientific instrument sector within ninemonths of the Company's strategic entrance into this specialist area. UHV is anexcellent company and we are confident that this acquisition will serve tosignificantly enhance earnings with immediate effect." For further information please contact: David Cicurel, Chief Executive, Judges Capital: Tel: 07771 893 080 Alex Borrelli, Shore Capital & Corporate: Tel: 020 7408 4090 Melvyn Marckus, Cardew Group: Tel: 020 7930 0777 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Jun 20264:34 pmRNSDirector/PDMR Shareholding
1st Jun 20262:24 pmRNSTotal Voting Rights
26th May 20265:18 pmRNSPurchase of Ordinary Shares
20th May 20262:52 pmRNSResult of AGM
11th May 20263:10 pmRNSDirector/PDMR Shareholding
8th May 20265:05 pmRNSDirector/PDMR Shareholding
28th Apr 20267:00 amRNSNotice of AGM
22nd Apr 202611:53 amRNSConfirmation of Full Year Results
9th Apr 202611:14 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSUnaudited Preliminary Results
25th Mar 20267:00 amRNSNotice of Investor Presentation
10th Mar 20267:00 amRNSDirector/PDMR Shareholding
9th Feb 20261:49 pmRNSDirector/PDMR Shareholding
2nd Feb 20269:38 amRNSTotal Voting Rights
29th Jan 20263:31 pmRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNSGrant of Options
22nd Jan 20267:00 amRNSFull Year Trading Statement and Notice of Results
8th Jan 202611:18 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSBlocklisting Return
22nd Dec 20257:00 amRNSBlocklisting Return
9th Dec 202510:25 amRNSDirector/PDMR Shareholding
3rd Dec 20257:00 amRNSAcquisition of the minority shareholding in GdB
26th Nov 20257:00 amRNSBoard Succession
13th Nov 20255:05 pmRNSDirector/PDMR Shareholding
11th Nov 202512:08 pmRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNSTotal Voting Rights
20th Oct 20257:00 amRNSDirector/PDMR Shareholding
8th Oct 202511:43 amRNSDirector/PDMR Shareholding
1st Oct 202512:22 pmRNSTotal Voting Rights
18th Sep 20257:00 amRNSInterim Results
9th Sep 202511:42 amRNSDirector/PDMR Shareholding
21st Aug 20257:00 amRNSNotice of Investor Presentation
6th Aug 20255:46 pmRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
30th Jul 20257:00 amRNSDirector/PDMR Shareholding
25th Jul 202510:07 amRNSDirector/PDMR Shareholding
24th Jul 20254:06 pmRNSDirector/PDMR Shareholding
24th Jul 20257:00 amRNSHalf Year Trading Update
8th Jul 20253:53 pmRNSDirector/PDMR Shareholding
1st Jul 20255:08 pmRNSTotal Voting Rights
1st Jul 20257:00 amRNSAppointment of Group Acquisitions Executive
23rd Jun 20257:00 amRNSBlocklisting Return
9th Jun 20251:37 pmRNSDirector/PDMR Shareholding
4th Jun 20255:03 pmRNSPurchase of Ordinary Shares
30th May 202512:06 pmRNSTotal Voting Rights
23rd May 202511:25 amRNSResult of AGM
13th May 20255:18 pmRNSPurchase of Ordinary Shares
8th May 20255:27 pmRNSDirector/PDMR Shareholding
28th Apr 20257:00 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.